Page last updated: 2024-10-26

domperidone and Lung Diseases

domperidone has been researched along with Lung Diseases in 1 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vadász, I1

Other Studies

1 other study available for domperidone and Lung Diseases

ArticleYear
Examination of Motilium in the prevention of gastro-intestinal side-effects of different drugs used in pulmonology.
    Therapia Hungarica (English edition), 1988, Volume: 36, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Domperidone; Female; Gastrointestinal Diseases; Humans; Lung Dis

1988